Stereotaxis director granted 43,103 RSUs

Curet Myriam reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Curet Myriam reported acquisition or exercise transactions in this Form 4 filing.

Stereotaxis, Inc. director Myriam Curet reported receiving an equity award of 43,103 restricted share units, each representing one share of common stock. The grant was made at no cash cost to her and increased her directly owned stake to 435,161 shares.

The restricted share units vest on the earliest of the fifth anniversary of the award date, the end of her board service, or a defined Change of Control event, aligning her compensation with the company’s long-term performance and governance outcomes.

Insider Trade Summary

Grant/Award: 43,103 shares

Grant/Award 1 txn

Insider Curet Myriam

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	43,103	$0.00	$0.00

Holdings After Transaction: Common Stock — 435,161 shares (Direct)

Footnotes (1)

1. F1. Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

Key Figures

RSU grant size: 43,103 units Price per share: $0.0000 Shares after transaction: 435,161 shares +1 more

4 metrics

RSU grant size 43,103 units Restricted share units awarded to director Myriam Curet

Price per share $0.0000 Stated transaction price for the RSU grant

Shares after transaction 435,161 shares Total directly held by Myriam Curet following the grant

Maximum vesting period 5 years Vests no later than fifth anniversary of award date

Key Terms

restricted share units, Change of Control, board of directors

3 terms

restricted share units financial

"Grant of restricted share units. Each restricted share unit represents a right to receive one share"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

Change of Control financial

"or (iii) a Change of Control (as defined in the award documents)."

A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.

board of directors financial

"the date on which the service of the director on the board of directors terminates"

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Stereotaxis (STXS) director Myriam Curet report?

Director Myriam Curet reported an equity award of 43,103 restricted share units. Each unit represents one Stereotaxis common share, granted at no cash cost as part of her director compensation package, increasing her reported direct holdings to 435,161 shares.

How many Stereotaxis (STXS) shares does Myriam Curet hold after this Form 4?

After the reported award, Myriam Curet directly holds 435,161 Stereotaxis shares. This total includes the 43,103 restricted share units granted in the transaction, which convert into common stock as they vest under the terms of the award.

What are the vesting terms of Myriam Curet’s 43,103 Stereotaxis restricted share units?

The 43,103 restricted share units vest on the earliest of three events: the fifth anniversary of the award date, the termination of Curet’s board service, or a defined Change of Control. These conditions tie the award’s value to long-term service and corporate events.

Did Myriam Curet pay cash for the Stereotaxis shares reported in this Form 4?

No cash was paid for these shares; the Form 4 lists a price per share of 0.0000. The 43,103 units represent a non-cash equity grant, a common structure for director compensation that aligns board members with shareholder interests over time.

Is Myriam Curet’s Stereotaxis Form 4 transaction a purchase or a grant?

The transaction is a grant, not an open-market purchase. It is coded as an "A" transaction, described as a grant, award, or other acquisition, reflecting restricted share units awarded as compensation rather than shares bought in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Curet Myriam

(Last) (First) (Middle)

C/O STEREOTAXIS, INC.

710 NORTH TUCKER BLVD., SUITE 110

(Street)

ST. LOUIS MISSOURI 63101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Stereotaxis, Inc. [ STXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		43,103(1)	A	$0	435,161	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted share units. Each restricted share unit represents a right to receive one share of common stock. The restricted share units vest on the earliest to occur of (i) the fifth anniversary of the date of the award, (ii) the date on which the service of the director on the board of directors terminates, or (iii) a Change of Control (as defined in the award documents).

	/s/ Kimberly R. Peery, Attorney-in-Fact for Myriam Curet	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)